Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Graybug Vision, Inc. (GRAY : NSDQ)
 
 • Company Description   
Graybug Vision Inc. is a clinical-stage biopharmaceutical company. It is focused on developing transformative medicines to treat chronic vision-threatening diseases of the retina and optic nerve. The company's product candidate includes GB-102, GB-401 and GB-103 which are in clinical stage. Graybug Vision Inc. is headquartered in Redwood City, California.

Number of Employees: 27

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.89 Daily Weekly Monthly
20 Day Moving Average: 44,215 shares
Shares Outstanding: 21.36 (millions)
Market Capitalization: $19.01 (millions)
Beta: 2.39
52 Week High: $7.06
52 Week Low: $0.72
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -22.61% -15.20%
12 Week -28.80% -22.75%
Year To Date -51.37% -42.17%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
203 REDWOOD SHORES PARKWAY SUITE 620
-
REDWOOD CITY,CA 94065
USA
ph: 650-487-2800
fax: -
None None
 
 • General Corporate Information   
Officers
Frederic Guerard - Chief Executive Officer
Christy Shaffer - Chairperson; Director
Robert S. Breuil - Chief Financial Officer
Eric Bjerkholt - Director
Gerald Cagle - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 38942Q103
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/10/22
Share - Related Items
Shares Outstanding: 21.36
Most Recent Split Date: (:1)
Beta: 2.39
Market Capitalization: $19.01 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.37 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.71 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/10/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.34
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: 11.11%
vs. Previous Quarter: -17.07%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -50.75
12/31/21 - -47.70
09/30/21 - -43.98
ROA
03/31/22 - -47.76
12/31/21 - -44.86
09/30/21 - -41.24
Current Ratio
03/31/22 - 13.77
12/31/21 - 16.53
09/30/21 - 16.59
Quick Ratio
03/31/22 - -
12/31/21 - 16.53
09/30/21 - 16.59
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - 2.63
12/31/21 - 3.05
09/30/21 - 3.39
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©